⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9940943 | 0.66 | — | — | |
| SCHEMBL28654103 | 0.55 | CRBN (0.37) | — | |
| SCHEMBL1137718 | 0.54 | CRBN (0.31) | — | |
| SCHEMBL17847641 | 0.51 | CRBN (0.31) | — | |
| SCHEMBL15547045 | 0.50 | — | — | |
| SCHEMBL30786015 | 0.50 | GSK3A (0.36) | — | |
| SCHEMBL6569434 | 0.49 | CRBN (0.53) | — | |
| SCHEMBL5752288 | 0.48 | CYP19A1 (0.34) | — | |
| SCHEMBL1137425 | 0.48 | MAPT (0.36) | — | |
| SCHEMBL5386997 | 0.47 | MAPT (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554683-A2 | METHOD FOR TREATING BREAST CANCERS AND PARP RESISTANT BREAST CANCERS | Lantern Pharma Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024016014-A2 | METHOD FOR TREATING BREAST CANCERS AND PARP RESISTANT BREAST CANCERS | LANTERN PHARMA INC. (US) | 2024-01-18 | — | — | WO | disclosed |